43 studies found for:    0815
Show Display Options
Rank Status Study
1 Completed Relapse Prevention With Varenicline
Conditions: Recurrence;   Smoking Cessation;   Substance-Related Disorders
Interventions: Drug: Varenicline;   Drug: Placebo
2 Completed
Has Results
Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
Condition: Pancreatic Cancer
Interventions: Drug: Sorafenib;   Drug: Erlotinb
3 Completed Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
Conditions: Childhood Central Nervous System Choriocarcinoma;   Childhood Central Nervous System Embryonal Tumor;   Childhood Central Nervous System Germ Cell Tumor;   Childhood Central Nervous System Germinoma;   Childhood Central Nervous System Mixed Germ Cell Tumor;   Childhood Central Nervous System Teratoma;   Childhood Central Nervous System Yolk Sac Tumor;   Metastatic Childhood Soft Tissue Sarcoma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Central Nervous System Embryonal Tumor;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Childhood Visual Pathway Glioma;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: pazopanib hydrochloride;   Other: pharmacological study
4 Terminated Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma
Condition: Melanoma
Intervention:
5 Recruiting Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: triptorelin;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
6 Completed Hypopituitarism After Aneurismal Subarachnoid Hemorrhage
Conditions: Aneurismal Subarachnoid Hemorrhage;   Hypopituitarism;   Neuropsychological Deficits
Intervention:
7 Completed A Key Link for Transmission Prevention
Condition: HIV
Interventions: Behavioral: Standard HIV prevention messages;   Behavioral: 5 counselor-delivered sessions;   Drug: ARVs with raltegravir and emtricitabine/tenofovir disoproxil fumarate
8 Recruiting Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease
Conditions: Stable Coronary Artery Disease;   Obesity;   Impaired Glucose Tolerance
Interventions: Other: training;   Other: training + metformin;   Other: training + glitazon
9 Completed Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)
Condition: Gout
Interventions: Biological: Rilonacept;   Other: Placebo
10 Recruiting Enhancement of Hand Motor Function After Cervical Spinal Cord Injury
Condition: Spinal Cord Injury
Interventions: Procedure: High frequency non-invasive repetitive transcranial magnetic stimulation;   Procedure: Sham rTMS over control brain area
11 Recruiting Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
Conditions: Mesothelioma;   Pleural Mesothelioma
Interventions: Drug: Pemetrexed;   Drug: Cisplatin
12 Completed Lung Deposition of the BDP/Formoterol Combination Administered Via the NEXT DPI in Healthy, Asthmatic and COPD Patients
Conditions: Pulmonary Disease, Chronic Obstructive;   Asthma
Intervention: Drug: BDP/formoterol NEXT DPI
13 Completed A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis
Conditions: Gastric Cancer;   Neoplasm Metastasis
Interventions: Drug: 5-FU continuous infusion;   Drug: MTX + 5-FU sequential therapy
14 Recruiting Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC
Condition: Hepatic Neoplasm Malignant Recurrent
Interventions: Drug: NIK-333(peretinoin);   Drug: Placebo
15 Completed Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion
Condition: Malignant Pericardial Effusion
Interventions: Procedure: Observation alone after pericardial drainage;   Drug: Pericardial instillation of bleomycin after drainage
16 Unknown  A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)
Condition: Colorectal Neoplasms
Interventions: Drug: 5FU+l-leucovorin;   Drug: UFT+Leucovorin
17 Recruiting Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212)
Condition: Rectal Neoplasms
Interventions: Procedure: Mesorectal excision with lateral lymph node dissection;   Procedure: Mesorectal excision without lateral lymph node excision
18 Unknown  Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
Condition: Colorectal Cancer
Interventions: Drug: tegafur-uracil;   Genetic: polymerase chain reaction;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: diagnostic laboratory biomarker analysis
19 Active, not recruiting A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Patients With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib
Condition: Hepatocellular Carcinoma
Interventions: Biological: Placebo;   Biological: Ramucirumab DP (IMC-1121B)
20 Terminated Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Conditions: Adenocarcinoma of the Pancreas;   Advanced Solid Tumors;   Cancer;   Cancer of Pancreas;   Cancer of the Pancreas;   Metastases;   Metastatic Cancer;   Metastatic Pancreatic Cancer;   Pancreas Cancer;   Pancreatic Cancer;   Bone Metastases;   Endocrine Cancer;   Oncology;   Oncology Patients;   Solid Tumors;   Advanced Malignancy
Interventions: Drug: AMG 479;   Drug: Placebo;   Drug: gemcitabine

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years